Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Inflamm Bowel Dis ; 30(3): 482-495, 2024 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-37738641

RESUMO

Inflammatory bowel disease (IBD) is a chronic relapsing condition with no known etiology and is characterized by disrupted gut homeostasis, chronic inflammation, and ulcerative lesions. Although current treatments can reduce disease activity, IBD frequently recurs once treatments are discontinued, indicating that treatments are ineffective in providing long-term remission. The lack of responsiveness and reluctance of some affected persons to take medications because of potential adverse effects has enhanced the need for novel therapeutic approaches. The vagus nerve (VN) is likely important in the pathogenesis of IBD, considering the decreased activity of the parasympathetic nervous system, especially the VN, and the impaired interaction between the enteric nervous system and central nervous system in patients with IBD. Vagus nerve stimulation (VNS) has demonstrated anti-inflammatory effects in various inflammatory disorders, including IBD, by inhibiting the production of inflammatory cytokines by immune cells. It has been suggested that stimulating the vagus nerve to induce its anti-inflammatory effects may be a potential therapeutic approach for IBD. Noninvasive techniques for VNS have been developed. Considering the importance of VN function in the brain-gut axis, VNS is a promising treatment option for IBD. This review discusses the potential therapeutic advantages and drawbacks of VNS, particularly the use of noninvasive transcutaneous auricular vagus nerve stimulation.


As some patients do not respond well to current treatments, novel therapeutic approaches are needed for inflammatory bowel disease (IBD). With diminished parasympathetic anti-inflammatory activity in IBD patients, especially in the vagus nerve, stimulation of the vagus nerve may be a potential therapeutic approach.


Assuntos
Doenças Inflamatórias Intestinais , Estimulação do Nervo Vago , Humanos , Eixo Encéfalo-Intestino , Doenças Inflamatórias Intestinais/terapia , Citocinas , Anti-Inflamatórios
2.
Int J Immunogenet ; 50(1): 24-33, 2023 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-36328955

RESUMO

Endometriosis is an inflammatory disease characterized by the presence of ectopic endometrial tissue, immune cell dysfunction and abnormal cytokine secretion. In addition to immunological factors, genetic variations that influence endometriosis severity and cytokine expression levels play important roles in the pathogenesis of this disease. Interleukin-12 (IL-12), specifically its p40 subunit encoded by IL-12B gene and the interleukin-12 receptor ß1 (IL-12Rß2) chain of its receptor, as well as interleukin-27 (IL-27) are important in the establishment of endometriosis. So, in this study, we measured IL-12 and IL-27 serum levels and investigated the possible links between IL-12B rs3212227, IL-12Rß2 rs3790565 and IL-27 rs153109 polymorphisms and the risk of developing endometriosis in a group of Iranian women. In this case-control study, 162 endometriosis patients and 151 healthy women were included and tested for the aforementioned polymorphisms using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique. The enzyme-linked immunosorbent assay (ELISA) method was also used to measure IL-12 and IL-27 serum levels. Although there was no statistically significant association between the genotypes and alleles of the studied polymorphisms and the development of endometriosis in general, the AA genotype of IL-12B rs3212227 showed a significant association with uterine endometriosis when compared to AC+CC genotypes (p = .04, CI = 0.270-0.988, OR = 0.517). Indeed, the AA genotype of the IL-12B rs3212227 single nucleotide polymorphism (SNP) may be linked with a lower risk of developing uterine endometriosis. There was no significant difference in IL-27 levels between the two studied groups (p = .49), and IL-12 levels were undetectable in both groups. In conclusion, the AA genotype of IL-12B rs3212227 might be associated with a decreased risk of uterine involvement in endometriosis patients.


Assuntos
Endometriose , Interleucina-27 , Humanos , Feminino , Interleucina-12/genética , Interleucina-27/genética , Irã (Geográfico) , Receptores de Interleucina-12/genética , Endometriose/genética , Estudos de Casos e Controles , Genótipo , Polimorfismo de Nucleotídeo Único , Citocinas/genética , Subunidade p40 da Interleucina-12/genética , Predisposição Genética para Doença , Frequência do Gene
3.
J Matern Fetal Neonatal Med ; 35(25): 6600-6609, 2022 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-34275427

RESUMO

OBJECTIVE: This systematic review and meta-analysis study was performed to assess the potential association between interleukin-1 beta (IL-1ß) single nucleotide polymorphisms (SNPs) (rs1143634 and rs16944) and interleukin-6 (IL-6) SNP (rs1800795) and pre-eclampsia (PE). METHODS: A comprehensive literature search was conducted in the international search engines and databases, including MEDLINE (via PubMed), Scopus, and Web of Science (ISI) up to 9 March 2021. After retrieving relevant articles, data extraction was performed by four authors independently. Pooled ORs and corresponding 95% CIs were used to evaluate the association between IL-1ß and IL-6 polymorphisms and PE risk. Cochran's Q test was used to check heterogeneity, and the I2 index was calculated for measuring the heterogeneity between the estimations of included studies. RESULTS: After reviewing fully published studies, 21 studies were included in this study based on the eligibility criteria. Our results showed that rs16944 and rs1143634 of IL-1ß were significantly associated with the risk of PE. Regarding rs16944, the minor C allele significantly decreased the risk of PE (C vs. T: OR = 0.79, 95% CI = 0.69-0.90). In contrast, the minor T allele of rs1143634 significantly increased the risk of PE (T vs. C: OR = 1. 28, 95% CI = 1.04-1.58). There was no significant association between IL-6 rs1800795 (C vs. G: OR = 1.04, 95% CI = 0.93-1.16) polymorphism and PE risk. CONCLUSIONS: In conclusion, this meta-analysis suggests rs1143634 and rs16944 polymorphisms of IL-1ß are related to the risk of PE.


Assuntos
Interleucina-1beta , Interleucina-6 , Pré-Eclâmpsia , Feminino , Humanos , Gravidez , Predisposição Genética para Doença , Interleucina-1beta/genética , Interleucina-6/genética , Polimorfismo de Nucleotídeo Único , Pré-Eclâmpsia/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...